Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29987768 | 1.00 | CCKAR (1.00) | CCKARCCKBR | |
| SCHEMBL3997648 | 1.00 | CCKAR (1.00) | CCKARCCKBR | |
| SCHEMBL3996878 | 1.00 | CCKAR (1.00) | CCKARCCKBR | |
| SCHEMBL7971407 | 0.89 | CCKAR (0.79) | CCKARCCKBR | |
| SCHEMBL2183648 | 0.82 | CCKAR (0.69) | CCKARCCKBR | |
| SCHEMBL2183643 | 0.82 | CCKAR (0.69) | CCKARCCKBR | |
| SCHEMBL3996882 | 0.80 | CCKAR (0.67) | CCKARCCKBR | |
| SCHEMBL5641175 | 0.80 | CCKAR (0.67) | CCKARCCKBR | |
| SCHEMBL24133346 | 0.80 | CCKAR (0.67) | CCKARCCKBR | |
| SCHEMBL30272388 | 0.80 | CCKAR (0.67) | CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1532105-B1 | ANTHRANYL DERIVATIVES HAVING AN ANTICHOLECYSTOKININ ACTIVITY (ANTI-CCK-1), A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL USE THEREOF | ROTTAPHARM SPA (IT) | 2009-06-10 | — | — | EP | disclosed |
| US-7294648-B2 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof | ROTTAPHARM S.P.A. (IT) | 2007-11-13 | — | — | US | disclosed |
| US-20060111304-A1 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof | ROTTAPHARM S.P.A. (IT) | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111304-A1 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof | CCKAR, CCKBR, SSTR2 | CCKAR 1/4885CCKBR 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.